| Name | (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-phenylpropanoyl]amino]hexanoic acid |
|---|---|
| Synonyms | L-Lysine,L-lysyl-L-arginyl-L-phenylalanyl |
| Description | KRFK, a peptide derived from TSP-1, can activate TGF-β. KRFK promotes TGF-β-mediated signaling and its downstream role, independent of thrombospondin (TSP) receptors such as CD47 and CD36. KRFK can be used for chronic ocular surface inflammatory disorders reseach[1]. |
|---|---|
| Related Catalog | |
| Target |
TGF-β[1] |
| In Vitro | KRFK (50 μm; 24 h) 激活 TGF-β 的分泌,降低 TSP-1 缺陷骨髓源性树突状细胞 (BMDCs) 中 DC 成熟标记物的表达[1]。 |
| In Vivo | KRFK (单只眼用药 5 μg/5 μL; 单剂量) 显著预防 TSP-1-/- 小鼠慢性眼表炎症的发生[1]。 |
| References |
| Molecular Formula | C27H47N9O5 |
|---|---|
| Molecular Weight | 577.71900 |
| Exact Mass | 577.37000 |
| PSA | 275.03000 |
| LogP | 4.42940 |